The Short Version
Available evidence supports this mechanism. Creatine supplementation suppresses endogenous creatine synthesis, and that synthesis normally uses SAMe to methylate guanidinoacetate into creatine, so the pathway’s SAMe demand falls. Unchanged blood SAM, SAH, or homocysteine in some trials does not negate this, because those markers do not directly measure pathway flux.